The conference consists of
- talks given in Oxford
- online 'e-Presentations' and Webmeetings - an innovative alternative to posters
All talks and Webmeetings will be recorded and made available to all registered delegates until 5th October 2020. Talks given in Oxford will be live-streamed.
MONDAY 6th APRIL
|
12.00 – 12.50 |
Registration |
|
|
12.50 - 13.00 |
Welcome |
|
|
|
|
|
|
13.00 - 13.30 |
Ed Domino |
Training the ketamine tiger |
|
13.30 - 14.30 |
Carlos Zarate |
Uncovering the neurobiological mechanisms of ketamine’s therapeutic effects |
|
|
|
|
|
14.30 – 15.00 |
Afternoon Tea |
|
|
|
|
|
|
15.00 - 15.30 |
Elias Dakwar |
Ketamine for addiction |
|
15.30 - 16.00 |
Sunjeev Kamboj |
Disruption of reconsolidation in heavy alcohol use |
|
16.00 – 16.30 |
Celia Morgan |
Alcohol relapse prevention |
|
| ||
|
18.00 – 20.00 |
Debate & Reception at Convocation House, Divinity Schools (behind Sheldonian Theatre)
|
|
|
18.00 – 19.00 |
The Lancet Psychiatry debate: ‘This house believes that there is sufficient evidence for the wide prescription of ketamine for resistant depression’ For: Jerry Sanacora, Rupert McShane Against: Carl Heneghan, Ioana Cristea (TBC) |
|
|
19.00 – 20.00 |
Conference Reception Includes Tours of Duke Humphrey’s Library |
|
TUESDAY 7th APRIL
|
08.30 – 09.00 |
Registration |
|
|
|
|
|
|
09.00 – 09.40 |
Emma Robinson |
Review of neuropsychological effects of ketamine in rodents |
|
09.40 – 10.00 |
Robert Schoevers |
Open label long term oral esketamine treatment |
|
10.00 – 10.30 |
Giselle Pickering |
Prolonging the effect of ketamine with an NMDA antagonist |
|
|
|
|
|
10.30 – 11.00 |
Coffee |
|
|
|
|
|
|
11.00 – 11.40 |
Jerry Sanacora |
Translational studies |
|
11.40 – 12.10 |
Allan Schatzberg |
The opiate based effect of ketamine |
|
12.10 – 12.30 |
TBC |
|
|
|
|
|
|
12.30 – 14.00 |
Lunch |
|
|
|
|
|
|
14.00 – 14.40 |
Paul Glue |
RCTs of ketamine in anxiety disorders & slow release formulation |
|
14.40 – 15.05 |
Steve Levine |
Switching between ketamine and esketamine |
|
15.05 – 15.30 |
Lori Calabrese |
Real world effects of 6 IV infusions in 231 outpatients |
|
|
|
|
|
15.30 – 16.00 |
Tea |
|
|
|
|
|
|
16.00 – 16.15 |
Judith Nottage |
Effect of ketamine and D-cycloserine on high frequency EEG oscillations |
|
16.15 - 16.30 |
Vasileia Kotoula |
Delayed effects of ketamine on connectivity during an autobiographical memory task in remitted depressed subjects |
|
16.30 – 17.00 |
Jeff Becker |
Putting it all together – some hypotheses |
|
|
|
|
|
19.00 – 22.00 |
Conference dinner at Exeter College |
|
WEDNESDAY 8th APRIL
|
08.30 – 09.00 |
Registration |
|
|
|
|
|
|
09.00 – 09.30 |
Sai-Ying Wang |
Post-partum depression prevention with a ketamine infusion |
|
09.30 – 09.50 |
Adam Bayes |
The Ketamine Side Effects Tool |
|
10.00 – 10.30 |
Vanina Popova |
Learnings from SUSTAIN-2, a long-term phase-3 study of esketamine in patients with treatment-resistant depression |
|
|
|
|
|
10.30 – 11.00 |
Coffee |
|
|
|
|
|
|
11.00 – 11.15 |
Tobias Marton |
Delayed response to ketamine in the elderly |
|
11.15 – 11.30 |
Jennifer Dore |
Complex PTSD and ketamine assisted psychotherapy |
|
11.30 – 11.45 |
C. Sophia Albott |
Repeated Ketamine Infusions for PTSD and Depression |
|
11.45 - 12.30 |
HOT TOPICS |
|
|
12.30 – 14.00 |
Lunch |
|
|
|
|
|
|
14.00 – 14.40 |
Elizabeth Ballard |
Rapid Effects and Potential Biomarkers of Suicide Ideation Response to Ketamine |
|
14.30 – 15.10 |
Carla Canuso |
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in MDD Patients with Active Suicidal Ideation with Intent: Results from the Phase 3 ASPIRE Program. |
|
15.10 – 15.30 |
Rupert McShane |
A UK registry for antidepressants with abuse potential |
|
|
|
|
|
15.30 – 16.00 |
Tea |
|
|
|
|
|
|
16.00 – 16.30 |
TBC |
|